You are here : Home / Annual Results / DIVIS LABORATORIES LTD

DIVIS LABORATORIES Financials & Share Price [BOM: 532488|NSE : DIVISLAB]

The Revenues of DIVIS LABORATORIES have increased by 29.20% YoY.
The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 44.14 % YoY.
Y-o-Y REVENUES OPERATING MARGIN PROFIT AFTER TAX EPS ROCE Details👇

DIVIS LABORATORIES Share Price vs Sensex

Current Share Price : ₹5,083.8
Current MarketCap: ₹ 134,974.9 Cr
Updated EOD on :Oct 22,2021

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-4.8%

-1.2%

67.8%

SENSEX

-1.5%

3.2%

52.4%

Smart-Investing
What is the Intrinsic Value of DIVIS LABORATORIES ?

DIVIS LABORATORIES Last 5 Annual Results
[BOM: 532488|NSE : DIVISLAB]

ConsolidatedMar2021
Mar2020
Mar2019
Mar2018
Mar2017
Revenues ₹6,969 Cr₹5,394 Cr₹4,946 Cr₹3,891 Cr₹4,064 Cr
Expenses ₹4,108 Cr₹3,571 Cr₹3,073 Cr₹2,629 Cr₹2,617 Cr
Operating Profit (Excl OI) ₹2,861 Cr₹1,823 Cr₹1,873 Cr₹1,263 Cr₹1,447 Cr
Other Income ₹63 Cr₹190 Cr₹156 Cr₹113 Cr₹75 Cr
Interest ₹2.10 Cr₹7.14 Cr₹4.68 Cr₹2.37 Cr₹3.36 Cr
Depreciation ₹256 Cr₹186 Cr₹169 Cr₹142 Cr₹123 Cr
Profit Before Tax ₹2,666 Cr₹1,819 Cr₹1,855 Cr₹1,231 Cr₹1,395 Cr
Profit After Tax ₹1,984 Cr₹1,377 Cr₹1,353 Cr₹877 Cr₹1,060 Cr
Consolidated Net Profit ₹1,984 Cr₹1,377 Cr₹1,353 Cr₹877 Cr₹1,060 Cr
Earnings Per Share (Rs)₹74.75₹51.86₹50.96₹33.04₹39.95
PAT Margin (%)28.4725.5227.3522.4125.82
ROE(%)23.9019.3021.0015.5521.98
ROCE(%)32.0725.3628.5021.6828.75
Total Debt/Equity(x)0.000.000.020.010.01
Key Financials
Market Cap : ₹ 134,974.9 Cr
Revenue (TTM) : ₹ 7,199.6 Cr
Net Profit(TTM) : ₹ 2,049.3 Cr
EPS (TTM) : ₹ 77.2
P/E (TTM) : 65.9

Check out Industry Peers

Peers & Returns1W1M1Y
DIVIS LABORATORIES -4.8% -1.2% 67.8%
SUN PHARMACEUTICAL INDUSTRIES -2.7% 5.6% 69.1%
DR REDDYS LABORATORIES -4.9% -4.4% -8%
CIPLA -0.9% -7.1% 19.3%
GLAND PHARMA -1.5% -4.6% NA
PIRAMAL ENTERPRISES -8.1% -2% 102.9%
CADILA HEALTHCARE -6% -10.5% 20.8%
TORRENT PHARMACEUTICALS -4.6% -3.9% 12.5%
ALKEM LABORATORIES -3% -3.7% 42.9%

What is the Fundamental Analysis of DIVIS LABORATORIES ?

DIVIS LABORATORIES Revenues
[BOM: 532488|NSE : DIVISLAB]

Revenues
Y-o-Y

29.20 %

5 Yr CAGR

14.43 %

Years Revenues % Change
Mar2021 ₹6,969 Cr
29.20
Mar2020 ₹5,394 Cr
9.06
Mar2019 ₹4,946 Cr
27.10
Mar2018 ₹3,891 Cr
-4.25
Mar2017 ₹4,064 Cr -
What is the Valuation of DIVIS LABORATORIES ?

DIVIS LABORATORIES Operating Profit
[BOM: 532488|NSE : DIVISLAB]

Operating Profit
Y-o-Y

56.93 %

5 Yr CAGR

18.58 %

Years Operating Profit % Change
Mar2021 ₹2,861 Cr
56.93
Mar2020 ₹1,823 Cr
-2.66
Mar2019 ₹1,873 Cr
48.33
Mar2018 ₹1,263 Cr
-12.74
Mar2017 ₹1,447 Cr -
Operating Margins
Y-o-Y

21.45 %

5 Yr CAGR

3.62 %

Years Operating Margin% % Change
Mar2021 41.05%
21.45
Mar2020 33.8%
-10.75
Mar2019 37.87%
16.70
Mar2018 32.45%
-8.87
Mar2017 35.61% -

DIVIS LABORATORIES Profit After Tax
[BOM: 532488|NSE : DIVISLAB]

Profit After Tax(PAT)
Y-o-Y

44.15 %

5 Yr CAGR

16.96 %

Years Profit After Tax % Change
Mar2021 ₹1,984 Cr
44.15
Mar2020 ₹1,377 Cr
1.76
Mar2019 ₹1,353 Cr
54.24
Mar2018 ₹877 Cr
-17.30
Mar2017 ₹1,060 Cr -
PAT Margins
Y-o-Y

11.56 %

5 Yr CAGR

2.47 %

Years PAT Margin(%) % Change
Mar2021 28.47 %
11.56
Mar2020 25.52 %
-6.69
Mar2019 27.35 %
22.04
Mar2018 22.41 %
-13.21
Mar2017 25.82 % -

DIVIS LABORATORIES Earnings Per Share (EPS)
[BOM: 532488|NSE : DIVISLAB]

EPS
Y-o-Y

44.14 %

5 Yr CAGR

16.96 %

Years EPS % Change
Mar2021 ₹75
44.14
Mar2020 ₹52
1.77
Mar2019 ₹51
54.24
Mar2018 ₹33
-17.30
Mar2017 ₹40 -

DIVIS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532488|NSE : DIVISLAB]

ROCE
Y-o-Y

26.46 %

5 Yr CAGR

2.77 %

Years ROCE % Change
Mar2021 32.07%
26.46
Mar2020 25.36%
-11.02
Mar2019 28.5%
31.46
Mar2018 21.68%
-24.59
Mar2017 28.75% -
What is the Valuation of DIVIS LABORATORIES ?
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

DIVIS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX50 -2% 3.1% 54.5%
S&P BSE LARGECAP -2.3% 3.1% 55%
S&P BSE 100 LARGECAP TMC -2.4% 2.8% 55.6%
S&P BSE 100 ESG INDEX -2.5% 3.5% 55.9%
S&P BSE 100 -2.5% 2.8% 55.9%
S&P BSE CARBONEX -2.5% 3.2% 55.8%
S&P BSE LARGE MIDCAP -2.7% 2.9% 57.9%
S&P BSE 200 -2.7% 2.8% 58.9%
S&P BSE 250 LARGEMIDCAP -2.9% 2.7% 59.4%
S&P BSE 500 -3.1% 2.7% 61.2%
S&P BSE ALLCAP -3.2% 2.7% 62.3%
S&P BSE DIVIDEND STABILITY -3.8% 6.3% 65%
S&P BSE LOW VOLATILITY -4.4% -3.2% 39.7%
S&P BSE HEALTHCARE -4.4% -5% 27.9%
S&P BSE MOMENTUM -5% 5.4% 53.9%
MFG -5% 1.6% 49.9%
S&P BSE QUALITY -5.1% 1.2% 49.6%
NSE Indices1W1M1Y
NIFTY 100 ALPHA 30 -1.3% 2.6% NA
NIFTY 50 -2% 3.2% 54.5%
NIFTY 100 -2.4% 2.6% 55.1%
NIFTY LARGE MIDCAP 250 -2.4% 4.3% 70.8%
NIFTY500 MULTICAP 50:25:25 -2.5% 4.2% NA
NIFTY 200 -2.8% 2.8% 58.7%
NIFTY 500 -3.1% 2.7% 60.9%
NIFTY ALPHA QTY VAL LOW-VOL 30 -3.5% -2.4% 44.9%
NIFTY QUALITY LOW-VOLATILTY 30 -3.5% -1.4% 44%
NIFTY ALPHA QTY LOW-VOLAT.30 -3.5% -2.2% 45.6%
NIFTY HEALTHCARE -3.7% -3.1% NA
NIFTY 100 EQUAL WEIGHT -3.9% 1.1% 66.8%
NIFTY200 QUALITY30 -4.2% -3.3% 42.2%
NIFTY PHARMA -4.4% -2.7% 19.9%
NIFTY ALPHA LOW-VOLATILTY 30 -4.9% -4.3% 42.5%

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


What is the share price of DIVIS LABORATORIES ?

The current share price of DIVIS LABORATORIES is ₹ 5,083.8.

What are the share price returns of DIVIS LABORATORIES ?

The share price returns of DIVIS LABORATORIES are as under:
1 Week : -4.8%
1 Month : -1.2%
1 Year : 67.8%

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD
Quarterly Results of PIRAMAL ENTERPRISES LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of ALKEM LABORATORIES LTD
Quarterly Results of LUPIN LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of LAURUS LABS LTD
Quarterly Results of IPCA LABORATORIES LTD

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z